DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Eikelboom JW, Wallentin L, Connolly SJ. et al.
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
Circulation 2011;
123: 2363-2372
We do not assume any responsibility for the contents of the web pages of other providers.